The Image Clarity Paradox: Higher CZT SPECT Contrast Does Not Always Translate to Diagnostic Accuracy for Alzheimer’s Disease
Tomography · 2025
DOI: 10.3390/tomography11060061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2025. Verfasst von Kiyotaka Nemoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Tomography, Emission-Computed, Single-Photon. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, KAKENHI.
Themen: Demenz
Abstract (Originalsprache)
Background
Recent advances in single-photon emission computed tomography (SPECT) technology, particularly cadmium–zinc–telluride (CZT) detectors, have improved spatial resolution and contrast in cerebral blood flow imaging. This study aimed to investigate whether these improvements translate to enhanced diagnostic accuracy for Alzheimer’s disease (AD).
Methods
We compared conventional SPECT (eCAM) with CZT SPECT in 29 patients (mean age 60.9 ± 17.6 years, 69% female) with suspected neurodegenerative diseases.
Results
Gray matter/white matter contrast was significantly higher in CZT SPECT compared to eCAM (1.615 ± 0.096 vs. 1.458 ± 0.068, p < 0.001). However, diagnostic accuracy for AD did not improve with CZT SPECT. For the participating psychiatrist, sensitivity decreased from 0.750 (eCAM) to 0.625 (CZT), while for the radiologist, specificity dropped from 0.571 (eCAM) to 0.429 (CZT). Overall accuracy slightly decreased for both readers.
Conclusions
These findings suggest that while CZT SPECT offers superior image quality, it may not immediately translate to improved diagnostic accuracy for AD. The study highlights the importance of specialized training for clinicians in interpreting higher-resolution CZT SPECT images to fully leverage their potential in neurodegenerative disease diagnosis. Future research should focus on developing standardized training protocols and larger, multi-center studies to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
- Department of Cardiovascular Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
- Department of Radiology, University of Tsukuba Hospital, Tsukuba 305-8576, Japan.
- Doctoral Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba 305-8574, Japan.
- Department of Diagnostic Image Analysis, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
ORCID-Profile: Kiyotaka Nemoto, Bryan J Mathis, Akemi Iwasaka, Tomohiro Kaneta, Tetsuaki Arai
Förderung
- Japan Society for the Promotion of Science, KAKENHI
Zitieren
APA
Nemoto, K., Mathis, B. J., Iwasaka, A., Nakayama, K., Kaneta, T., & Arai, T. (2025). The Image Clarity Paradox: Higher CZT SPECT Contrast Does Not Always Translate to Diagnostic Accuracy for Alzheimer’s Disease. Tomography. https://doi.org/10.3390/tomography11060061
Vancouver
Nemoto K, Mathis BJ, Iwasaka A, Nakayama K, Kaneta T, Arai T. The Image Clarity Paradox: Higher CZT SPECT Contrast Does Not Always Translate to Diagnostic Accuracy for Alzheimer’s Disease. Tomography. 2025. doi:10.3390/tomography11060061
BibTeX
@article{Nemoto2025,
author = {Nemoto, Kiyotaka and Mathis, Bryan J and Iwasaka, Akemi and Nakayama, Kenjiro and Kaneta, Tomohiro and Arai, Tetsuaki},
title = {The Image Clarity Paradox: Higher CZT SPECT Contrast Does Not Always Translate to Diagnostic Accuracy for Alzheimer’s Disease},
journal = {Tomography},
year = {2025},
doi = {10.3390/tomography11060061}
}
EUVIMED